Ablett G, Bishop C, Sheridan J W, Donald K J
Br J Exp Pathol. 1978 Oct;59(5):522-9.
Sera from DBA/2 and Quackenbush mice (which are non-immune for mastocytoma and Sarcoma 180 respectively) contain a heat-labile (56 degrees for 30 min) component(s) that inhibits the in vitro growth of DBA Mastocytoma P-815 X-2 and Sarcoma 180. Adsorption of the sera with tumour cells at 4 degrees did not eliminate the factor(s), suggesting that it is not an antibody. In liquid suspension cultures inhibitory activity was observed at concentrations of mouse serum of 10--20% and in semisolid agar clonogenic cell assays at concentrations as low as 1%. The influences of the inhibitor(s) for both tumours and in both culture systems were parallel. However, there was a quantitative difference in susceptibility to other environmental factors (FCS concentration, bicarbonate concentration, and O2 tension) between the two tumours. These results parallel the in vivo findings where intravenously injected mastocytoma cells produced more tumours than did Sarcoma 180.
来自DBA/2和夸肯布什小鼠(分别对肥大细胞瘤和肉瘤180无免疫力)的血清含有一种热不稳定成分(56℃ 30分钟),可抑制DBA肥大细胞瘤P-815 X-2和肉瘤180的体外生长。在4℃下用肿瘤细胞吸附血清并不能消除该因子,这表明它不是一种抗体。在液体悬浮培养中,当小鼠血清浓度为10%-20%时可观察到抑制活性,而在半固体琼脂克隆细胞试验中,浓度低至1%时也可观察到抑制活性。两种肿瘤在两种培养系统中,抑制剂的影响都是平行的。然而,这两种肿瘤对其他环境因素(胎牛血清浓度、碳酸氢盐浓度和氧气张力)的敏感性存在定量差异。这些结果与体内研究结果一致,即静脉注射的肥大细胞瘤细胞比肉瘤180产生更多的肿瘤。